Tetanus immune globulin
- Generic Name
- Tetanus immune globulin
- Brand Names
- Hypertet
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- V4SWI4RF4J
- Background
Tetanus Immune Globulin is manufactured from human plasma . It contains antibodies against tetanus toxoid and is primarily used as prophylaxis against tetanus in wounded patients.
- Indication
For use as prophylaxis against tetanus in patients who are injured and have incomplete of uncertain immunization status . May also be used in the treatment of active tetanus.
- Associated Conditions
- Tetanus
- Associated Therapies
- -
Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- Grifols Therapeutics LLC
- Target Recruit Count
- 6
- Registration Number
- NCT00437671
- Locations
- 🇺🇸
Long Island Jewish Medical Center, New Hyde Park, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath